Search Results - F. Piazza
- Showing 1 - 3 results of 3
-
1
349 | PEMBROLIZUMAB OR NIVOLUMAB COMBINED WITH BRENTUXIMAB‐VEDOTIN IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL B‐CELL LYMPHOMA: AN ITALIAN REAL‐LIFE STUDY by A. Broccoli, L. Argnani, A. Pinto, A. Gorgone, F. Piazza, C. Fozza, V. F. Fesce, F. Marino, M. Celli, E. Pennese, F. Gaudio, P. Lauzzana, L. Pezzullo, S. De Lorenzo, P. M. Nierychlewska, G. Ceparano, F. Pane, C. Romano, P. L. Zinzani
Published 2025Get full text
Artículo Open Access -
2
Exposure to obinutuzumab does not affect outcomes of SARS ‐ CoV ‐2 infection in vaccinated patients with newly diagnosed advanced‐stage follicular lymphoma by A. Pinto, M. Caltagirone, M. Battista, G. C. Gazzoli, C. Patti, E. Pennese, S. De Lorenzo, V. Pavone, M. Merli, A. Chiarenza, A. G. Gorgone, F. Piazza, B. Puccini, A. Noto, L. Arcaini, R. De Filippi, P. L. Zinzani, A. J. M. Ferreri, M. Ladetto, S. Ferrari, G. Gritti
Published 2024Get full text
Artículo Open Access -
3
51 | LONG‐TERM BENEFIT AND MOLECULAR FEATURES OF PATIENTS WITH HCV‐ASSOCIATED INDOLENT LYMPHOMAS TREATED WITH DIRECT‐ACTING ANTIVIRALS: 6‐YEAR FOLLOW‐UP OF THE FIL_BArT STUDY... by M. Merli, E. Genuardi, S. Zibellini, S. Rattotti, M. Spina, G. Roti, M. Motta, F. Piazza, C. Boccomini, A. J. Ferreri, O. Perbellini, M. Brociner, A. Dodero, D. Vallisa, A. Pulsoni, A. Santoro, V. Zuccaro, E. Chimienti, S. Russo, C. Varraso, E. Rizzo, A. Bosi, E. Cappello, G. Favrin, L. Marcheselli, C. Visco, S. Luminari, S. Ferrero, L. Arcaini
Published 2025Get full text
Artículo Open Access